- Home
- NVCR vs REAL Comparison
NVCR vs REAL Comparison
Compare NVCR & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCR
- REAL
- Stock Information
- Founded
- NVCR 2000
- REAL 2011
- Country
- NVCR Switzerland
- REAL United States
- Employees
- NVCR N/A
- REAL N/A
- Industry
- NVCR Medical/Dental Instruments
- REAL Other Specialty Stores
- Sector
- NVCR Health Care
- REAL Consumer Discretionary
- Exchange
- NVCR Nasdaq
- REAL Nasdaq
- Market Cap
- NVCR 1.3B
- REAL 1.4B
- IPO Year
- NVCR 2015
- REAL 2019
- Fundamental
- Price
- NVCR $11.25
- REAL $14.18
- Analyst Decision
- NVCR Buy
- REAL Buy
- Analyst Count
- NVCR 7
- REAL 8
- Target Price
- NVCR $28.64
- REAL $13.94
- AVG Volume (30 Days)
- NVCR 1.5M
- REAL 4.7M
- Earning Date
- NVCR 10-30-2025
- REAL 11-10-2025
- Dividend Yield
- NVCR N/A
- REAL N/A
- EPS Growth
- NVCR N/A
- REAL N/A
- EPS
- NVCR N/A
- REAL N/A
- Revenue
- NVCR $642,269,000.00
- REAL $662,789,000.00
- Revenue This Year
- NVCR $9.54
- REAL $14.56
- Revenue Next Year
- NVCR $5.70
- REAL $10.14
- P/E Ratio
- NVCR N/A
- REAL N/A
- Revenue Growth
- NVCR 11.17
- REAL 14.30
- 52 Week Low
- NVCR $10.70
- REAL $3.89
- 52 Week High
- NVCR $34.13
- REAL $16.24
- Technical
- Relative Strength Index (RSI)
- NVCR 35.05
- REAL 63.46
- Support Level
- NVCR $10.70
- REAL $10.49
- Resistance Level
- NVCR $12.01
- REAL $16.24
- Average True Range (ATR)
- NVCR 0.57
- REAL 0.98
- MACD
- NVCR -0.11
- REAL 0.20
- Stochastic Oscillator
- NVCR 15.48
- REAL 64.43
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.